Abelacimab Recruiting Phase 3 Trials for Deep Vein Thrombosis / Pulmonary Embolism / Venous Thromboembolism Treatment

Indications	Status	Purpose	Phase
DBCOND0029964 (Deep Vein Thrombosis) DBCOND0027915 (Pulmonary Embolism) DBCOND0000676 (Venous Thromboembolism)	Recruiting	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT05171049	A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE	Abelacimab (DB16682) Apixaban (DB06605)
NCT05171075	A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE	Abelacimab (DB16682) Dalteparin (DB06779)